News Medical on MSN
Hidden Immune Cell Population May Hold the Key To Stopping Fibrosis
Researchers discover circulating immune cells that drive fibrosis, revealing a new therapeutic target to prevent scar tissue ...
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval ...
Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell ...
Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are ...
Patients with moderate-to-severe AD can experience symptoms that disrupt sleep, thus impacting their daily activities and quality of life, said Druhan Howell, MD, a pediatric allergist and ...
Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years ...
The Health Service Executive (HSE) has approved BIMZELEX (bimekizumab) in Ireland for adults living with moderate-to-severe ...
New data supporting the safety and efficacy of tapinarof cream 1% (Vtama; Organon) for pediatric patients with atopic ...
New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests ...
The lone star tick along with the alpha-gal syndrome seems to be spreading in the U.S. Now there's been the first reported ...
Jeroncellevain, a company specializing in the production of prescription pharmaceuticals, announced on November 24 that it will hold the "PDRN Total ...
News Medical on MSN
New Immune Cell Suspects In Lupus
Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results